Shandong Historical Income Statement
000756 Stock | 16.21 0.14 0.87% |
Historical analysis of Shandong Xinhua income statement accounts such as Selling General Administrative of 800.1 M, Total Revenue of 6.2 B or Gross Profit of 1.8 B can show how well Shandong Xinhua Pharmaceutical performed in making a profits. Evaluating Shandong Xinhua income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shandong Xinhua's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Shandong Xinhua Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shandong Xinhua Phar is a good buy for the upcoming year.
Shandong |
About Shandong Income Statement Analysis
Shandong Xinhua Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shandong Xinhua shareholders. The income statement also shows Shandong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Shandong Xinhua Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Shandong Xinhua Phar generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Shandong Xinhua Pharmaceutical minus its cost of goods sold. It is profit before Shandong Xinhua operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Shandong Xinhua Phar. It is also known as Shandong Xinhua overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most accounts from Shandong Xinhua's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shandong Xinhua Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Xinhua Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. The current year's Tax Provision is expected to grow to about 52.1 M, whereas Interest Expense is forecasted to decline to about 38.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.8B | 2.0B | 2.4B | 1.8B | Total Revenue | 6.6B | 7.5B | 8.1B | 6.2B |
Shandong Xinhua income statement Correlations
Click cells to compare fundamentals
Shandong Xinhua Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shandong Xinhua income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 55.3M | 59.8M | 53.1M | 49.7M | 41.1M | 38.3M | |
Selling General Administrative | 893.9M | 736.9M | 688.9M | 814.9M | 967.0M | 800.1M | |
Total Revenue | 5.6B | 6.0B | 6.6B | 7.5B | 8.1B | 6.2B | |
Gross Profit | 1.9B | 1.8B | 1.8B | 2.0B | 2.4B | 1.8B | |
Other Operating Expenses | 63.0M | 58.2M | 60.3M | 59.3M | 68.2M | 66.0M | |
Operating Income | 458.2M | 542.9M | 499.0M | 543.4M | 612.2M | 440.3M | |
Net Income From Continuing Ops | 323.1M | 347.1M | 362.1M | 426.3M | 506.1M | 328.4M | |
Ebit | 361.2M | 390.3M | 458.8M | 403.7M | 464.2M | 400.3M | |
Research Development | 235.4M | 298.3M | 341.4M | 345.7M | 419.2M | 276.2M | |
Cost Of Revenue | 3.7B | 4.2B | 4.8B | 5.5B | 5.7B | 4.5B | |
Total Operating Expenses | 5.1B | 5.5B | 6.1B | 7.0B | 7.5B | 5.8B | |
Income Before Tax | 381.4M | 411.6M | 421.2M | 471.8M | 532.7M | 377.6M | |
Net Income Applicable To Common Shares | 255.3M | 300.0M | 324.9M | 348.5M | 400.8M | 258.3M | |
Net Income | 300.0M | 324.9M | 348.5M | 411.2M | 496.5M | 311.3M | |
Income Tax Expense | 58.3M | 64.5M | 59.2M | 45.5M | 52.3M | 51.8M | |
Minority Interest | 141.5M | 167.5M | (13.5M) | (15.1M) | (9.6M) | (9.1M) | |
Tax Provision | 58.3M | 64.5M | 59.2M | 45.5M | 26.6M | 52.1M | |
Net Interest Income | (56.7M) | (58.9M) | (48.7M) | (42.6M) | (31.8M) | (33.4M) | |
Interest Income | 3.6M | 6.0M | 8.8M | 10.5M | 12.3M | 7.2M | |
Ebitda | 781.3M | 856.8M | 908.7M | 1.0B | 1.2B | 887.2M | |
Reconciled Depreciation | 344.6M | 385.4M | 434.3M | 484.8M | 513.0M | 431.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shandong Stock
Shandong Xinhua Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shandong Xinhua shareholders. The income statement also shows Shandong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).